KOL KnockoutTM: Glaucoma Edition - Personalized Treatment Pl -

Media formats available:

Details

Presenters

Overview
Tune in for the third and final round of KOL Knockout^TM: Glaucoma Edition! Hosted by Douglas J. Rhee, MD, this championship round will feature Round #2 Winner Thomas D. Patrianakos, DO, along with contestants Leon W. Herndon Jr., MD, and Sameh Mosaed, MD.
The program will include a brief presentation followed by patient case studies. The panel members will weigh in on treatment options. YOU will be able to pose questions to the key opinion leaders and receive answers in real-time! You will also have the ability to vote on a KOL Knockout^TM: Glaucoma Edition winner of the program!
There will be learning, laughter, and only one KOL left standing!
This activity is supported by an unrestricted educational grant from Aerie Pharmaceuticals.
Learning Objectives
Upon completion of this activity, the participant should be able to:
- Describe the MOA of novel therapeutics and classes of drugs.
- Restate the most common side effects of novel therapeutics and explain the likelihood of achieving target intraocular pressure with monotherapy compared with combination regimens.
- Discuss the differences of branded versus generic glaucoma agents and identify patients at heightened risk for loss to follow-up.
- Evaluate and explain to patients the latest available treatments and determine which option is best for each patient.
Accreditation
This educational activity is provided by Evolve Medical Education LLC (Evolve).

Accreditation Statement
Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
Evolve Medical Education, LLC designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Evolve is a COPE-Accredited Administrator.
This activity, COPE Activity Number 123672 is accredited by COPE for continuing education for optometrists.
This course is approved for 1.5 hours of CE.
Course #77609-GL
Activity #123672
Participation Method
In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.
Course Viewing Requirements
Supported Browsers:
Internet Explorer 11 for Windows
Edge (recent versions; Chromium-based) for Windows
Google Chrome (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Mozilla Firefox (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Safari (recent versions) for Mac OSX, or iOS
Hardware Requirements:
4GB+ RAM
Recommended internet speed 5Mbps+
Faculty and Disclosures
Douglas J. Rhee, MD
Chair, Department of Ophthalmology and Visual Sciences
Director, University Hospitals Eye Institute
Case Western Reserve University School of Medicine
Cleveland, OH

Leon W. Herndon Jr, MD
Professor of Ophthalmology
Chief of Glaucoma Division
Duke Eye Center
Durham, NC

Sameh Mosaed, MD
Professor of Ophthalmology
Director of Glaucoma
The Gavin Herbert Eye Institute
University of California, Irvine
Irvine, CA

Thomas D. Patrianakos, DO
Chair of Ophthalmology
Cook County Health
Chicago, IL

DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.
The following faculty/staff members have the following financial relationships with ineligible companies.
Douglas J. Rhee, MD, has had a financial agreement or affiliation with the following ineligible companies in the form of Advisory Board: Ocular Therapeutix. Consultant: Aerie Pharmaceuticals, Allergan, and Ivantis. Grant/Research Support: Allergan, Glaukos, and Ivantis. Speaker’s Bureau: Aerie and Ivantis.
Leon W. Herndon Jr, MD, has had a financial agreement or affiliation with the following ineligible companies in the form of Consultant: Aerie, Alcon, Allergan, Genentech, Glaukos, New World Medical, Ocular Therapeutix, and Sight Sciences. Speaker's Bureau: Allergan and Genentech.
Sameh Mosaed, MD, has had a financial agreement or affiliation with the following ineligible companies in the form of Grant/Research Support: Sight Sciences. Speaker's Bureau: Aerie Pharmaceuticals and Bausch + Lomb.
Thomas D. Patrianakos, DO, has had no financial agreements or affiliations with ineligible companies.
The Evolve staff, planners and peer reviewer have no financial relationships with ineligible companies.
Disclaimer
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Aerie Pharmaceuticals.
System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
  Apple Safari for Mac OS and iOS
  Mozilla Firefox for Windows, Mac OS, iOS, and Android
  Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Release Date: 03/29/2022
Expiration Date: 04/05/2022

Douglas J. Rhee, MD

Host

Leon W. Herndon Jr, MD

Guest

Sameh Mosaed, MD

Guest

Thomas D. Patrianakos, DO

Guest

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

VBS Fellows’ Foray 2026: Through the Looking Glass—Real-World Vitreoretinal Surgical Cases
VBS Fellows’ Foray 2026: Through the Looking Glass—Real-World Vitreoretinal Surgical Cases
CME/CE
VBS Fellows’ Foray 2026: Through the Looking Glass—Real-World Vitreoretinal Surgical Cases
Yewlin E. Chee, MD; Camila Ventura MD, PhD
1.50 credits
- Yewlin E. Chee, MD
- Camila Ventura MD, PhD
- Edward Wood, MD
- Tony Capone Jr, MD
- Katherine E. Talcott, MD
- Nassim Abreu, MD
1.50 credits
Overcoming Cultural and Communication Disconnects, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
Overcoming Cultural and Communication Disconnects, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
CME/CE
Overcoming Cultural and Communication Disconnects, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
David Chin Yee, MD, FASRS
0.25 credits
- David Chin Yee, MD, FASRS
0.25 credits
A Case of Missed Diagnosis, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
A Case of Missed Diagnosis, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
CME/CE
A Case of Missed Diagnosis, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
Esther Lee Kim, MD
0.25 credits
- Esther Lee Kim, MD
0.25 credits
MinuteCE®
Lighting the Way: Exploring the Potential of Photobiomodulation for Dry AMD Treatment
Janis T. Eells, Ph.D.; David Boyer, MD
1.00 credit 8 episodes
- Janis T. Eells, Ph.D.
- David Boyer, MD
- Diana V. Do, MD
- Marion Munk, MD, Ph.D
1.00 credit 8 episodes

Recommended

Title